Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05386147 · ClinicalTrials.gov registry record · NA

Flourish HEC to Prevent Recurrence of BV

A NA study of Bacterial Vaginosis, sponsored by Vaginal Biome Science.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT05386147 is a NA study of Bacterial Vaginosis that has completed, run by Vaginal Biome Science. The registered enrollment target is 6 participants, below the 338-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05386147, a NA study of Bacterial Vaginosis, has completed, sponsored by Vaginal Biome Science.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

In a population of women with heightened vulvovaginal sensitivity and recurrent bacterial vaginosis (BV), the use of the Flourish HEC Vaginal Care System is being tested for prevention of BV recurrence over six months of use.

Conditions Studied

Interventions

  • DEVICE Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components)

Study Locations (1)

Pennsylvania

  • Center for Pelvic Medicine - Rosemont

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-12-22
Est. Completion 2022-11-15
Phase NA

Sponsor

Vaginal Biome Science

9 total trials

What the Registry Record Tells You About NCT05386147

The ClinicalTrials.gov registry entry for NCT05386147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 338-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (98% lower). The listed sponsor is Vaginal Biome Science, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bacterial Vaginosis appearing as the primary indexed condition, and to 1 intervention - of which Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components) is the first listed.

NCT05386147 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05386147 about?

NCT05386147 is a clinical study titled "Flourish HEC to Prevent Recurrence of BV". In a population of women with heightened vulvovaginal sensitivity and recurrent bacterial vaginosis (BV), the use of the Flourish HEC Vaginal Care System is being tested for prevention of BV recurrence over six months of use.

What is the current status of trial NCT05386147?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-12-22. Estimated completion is 2022-11-15.

What conditions does trial NCT05386147 study?

This clinical trial studies the following conditions: Bacterial Vaginosis.

What interventions are being tested in trial NCT05386147?

The interventions under investigation include: Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components) (DEVICE).

Who is sponsoring clinical trial NCT05386147?

This trial is sponsored by Vaginal Biome Science, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05386147 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bacterial Vaginosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.